Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
-31.28%
↓ 74% vs avg
Percentile
P44
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
-18.01%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -31.28% |
| Q3 2025 | 4.30% |
| Q2 2025 | 33.68% |
| Q1 2025 | 31.95% |
| Q4 2024 | -33.09% |
| Q3 2024 | -66.60% |
| Q2 2024 | -57.03% |
| Q1 2024 | 33.76% |
| Q4 2023 | -52.28% |
| Q3 2023 | 6.65% |
| Q2 2023 | -59.58% |
| Q1 2023 | -25.42% |
| Q4 2022 | -45.76% |
| Q3 2022 | -27.77% |
| Q2 2022 | 16.86% |
| Q1 2022 | -34.52% |
| Q4 2021 | 0.00% |